SUMMARY Antibody responses to the 14-valent pneumococcal capsular polysaccharide vaccine in children under school age were measured by enzyme-linked immunosorbent assay (ELISA) and radioimmunoassay (RIA). Specific IgG and IgM antibodies were usually detectable by ELISA in the prevaccination sera, and one or both of them increased as a response to the vaccination. Specific IgA antibodies were detected by ELISA in a part of the post-vaccination sera only. The frequency of the IgA responses increased with the age of the children. The correlation of the ELISA results with RIA was good (r from 0 652 to 0-812) except for type 6A (r = 0.471).
Antibodies against pneumococcal polysaccharides are most often measured by passive haemagglutinationl 2 or by radioimmunoassay (RIA), based on the Farr technique.3 The indirect immunofluorescence method has been used for detecting pneumococcal antibodies of different immunoglobulin classes in either serum or different secre- tions.4-7 Recently also the enzyme-linked immunosorbent assay (ELISA) has been applied to measure pneumococcal antibodies in the sera of adults. [8] [9] [10] [11] The method most commonly used for measuring antibody responses to pneumococcal vaccines and for evaluating the immunogenicity of their individual polysaccharide components has been radioimmunoassay.12-'4 This method in its commonly used form does not tell us which immunoglobulin classes participate in the antibody response to the vaccine. This information may, on the other hand, be especially pertinent when the vaccines are given to young children, whose responses to the polysaccharides are weaker than those of adults.12
We have therefore applied the ELISA method to measure the IgG, IgM, and IgA pneumococcal antibodies in sera of young children before and after vaccination with the currently used 14-valent pneumococcal vaccine. The results are compared with the total antibody values, measured by RIA, Accepted for publication 4 June 1980 to polysaccharides of six pneumococcal types commonly found in infections of this age group.
Material and methods

SERUM SPECIMENS
The sera were obtained from 29 children vaccinated intramuscularly with 14-valent pneumococcal cap *GMT (geometric mean titre) expressed as the dilution of the serum giving the absorbance of0 3 at 405 nm.
t AGMT: fold increase in geometric mean litres between pre-and post-vaccination sera or between pre-and booster-vaccination sera. §Pre: sera taken just before vaccination; post: sera taken two to three weeks after primary vaccination; booster: sera taken two to three weeks after booster vaccination given two months after primary vaccination. 
